To cite this paper use one of the standards below:
Ulcerative colitis (UC) is an inflammatory bowel disease markedely influenced by environmental factors. Consumption of a Western diet and elevated body mass have been described as possible facilitators of the disease. Contrarily, the intake of polyphenol-rich fruits may protect against pro-inflammatory conditions, like obesity and colitis. Considering that, the objective of this study was to investigate the effects of Brazilian native fruits on obese mice with UC induced by dextran sodium sulfate (DSS). C57BL/6 female mice (n=68) received a 35% (w/w) high-fat diet (HFD) supplemented or not with 5% (w/w) freeze-dried açaí pulp or jaboticaba peel. Control groups received the AIN-93M standard diet. After 13 weeks, 3% (w/v) DSS was included in water for five days to induce acute UC. One HFD group received daily mesalamine (200 mg/kg) via gavage as a treatment for UC. Body mass and disease activity index (DAI) were analyzed. After euthanasia, organ measurements were assessed. HFD induced obesity from week eight (p<0.05). Açaí anticipated that and largely increased fat deposits (p<0.0001). Jaboticaba delayed obesity and by week 13, decreased body mass by 25% (p<0.05), indicating its contribution to obesity prevention. Posteriorly, colitis was successfully induced, as seen by elevated DAI and colon weight/length ratio (p<0.001). Obesity didn’t enhance the colitis severity, and although proved by studies using animal models, the relation between obesity and UC is still debatable. Açaí and jaboticaba prevented against high DAI (0.13±0,23 and 0.48±0.48 vs. 1,68±0.73; p<0.001), due to reduced body mass loss, bleeding and diarrhea. Mice that received açaí gained large body mass, however, this didn’t exacerbate colitis. Mesalamine caused high mortality (33%) and had no positive effects, suggesting about its reverse role when given to obese mice. These results indicate that açaí and jaboticaba, even when embedded in a HFD, may constitute important allies as symptom relievers for UC.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper